MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Novel approach to MDS-UPDRS monitoring in clinical trials: Longitudinal Item Response Theory Models

    S. Luo, H. Zou, C. Goetz, D. Choi, D. Oakes, T. Simuni, G. Stebbins (Durham, USA)

    Objective: Using the unique advantages of Item Response Theory (IRT), we developed unidimensional and multidimensional models to investigate non-tremor and tremor MDS-UPDRS Part 3 changes…
  • MDS Virtual Congress 2021

    THE THERAPEUTIC EFFECT OF Bacopa monnieri (WATERHYSSOP) IN TREATING PARKINSON’S DISEASE

    N. Nizam, M. Ramli (Shah Alam, Malaysia)

    Objective: To determine the lethal concentration (LC50) of Bacopa monnieri aqueous extraction toward zebrafish. To analyse the behavioural study of zebrafish that has been exposed to rotenone…
  • MDS Virtual Congress 2021

    ELECTRICAL ACTIVITY OF THE MASTICATORY MUSCLES OF PARKINSONIANS INFLUENCED BY THE USE OF REMOVABLE DENTAL PROSTHESIS

    J. Oliveira, A. Sobral, T. Silva, M. Coriolano, C. Lins (Recife, Brazil)

    Objective: Analyze the influence of the types of dental prosthesis on the electromyographic activity of the masticatory muscles; masseter and temporal anterior in parkinsonians. Background:…
  • MDS Virtual Congress 2021

    COMPARISON OF FREQUENCY, CLINICAL PROFILE AND ETIOLOGIES OF PARKINSONISM IN 2008 AND 10 YEARS LATER AT THE NEUROLOGY DEPARTMENT OF BEFELATANANA UNIVERSITY TEACHING HOSPITAL, ANTANANARIVO, MADAGASCAR

    NF. Rasaholiarison, M. Ratsimandresy, JL. Rakotomanana, A. Tehindrazanarivelo (Fianarantsoa, Madagascar)

    Objective: To compare the frequency, the clinical profile of parkinsonism and its etiologies in 2008 and 10 years later in our department. Background: Number of…
  • MDS Virtual Congress 2021

    Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?

    M. Rossi, S. Perez-Lloret, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the time frame to the diagnosis of clinically established Parkinson’s disease (PD) or atypical parkinsonism after an acute levodopa challenge (LDC) for…
  • MDS Virtual Congress 2021

    Early-onset vs. Late-onset Parkinson’s disease

    H. Slimène, N. Farhat, S. Sakka, O. Hdiji, M. Dammak, C. Mhiri (Sousse, Tunisia)

    Objective: To determine the clinical and therapeutic peculiarities that distinguish Early onset Parkinson’s disease (EOPD) from late onset Parkinson’s disease (LOPD). Background: Age is the…
  • MDS Virtual Congress 2021

    Could Gender have an effect on Clinical and Transcranial Parenchymal Ultrasound Findings in Parkinson’s disease Patients?

    R. Soliman, N. Kishk, M. Oraby, A. Alsayyad, M. Abdel Salam, M. Abo Srea (Cairo, Egypt)

    Objective: We aimed to explore the possible differences between males and females as regarding motor, non-motor, depressive symptoms, cognitive functions and Transcranial Parenchymal Ultrasound (TCS)…
  • MDS Virtual Congress 2021

    Characteristics of daily exercise patterns in various stages of Parkinson’s disease

    J. Song, JK. Mun, JH. Ahn, J. Youn, I. Choi, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate the patterns of exercise in the daily lives of mild to severe PD patients. Background: Despite the reported clinical impact of exercise…
  • MDS Virtual Congress 2021

    Post-Covid-19 Parkinson’s disease: a Brazilian case series.

    J. Tavares, D. Oliveira, S. Gaspar, C. Gomes, M. Neto, P. Neto (Fortaleza, Brazil)

    Objective: To describe two patients with post-COVID-19 Parkinson’s disease (PD) and discuss their possible causes. Background: PD is a neurodegenerative disorder characterized by motor and…
  • MDS Virtual Congress 2021

    A case of dystonia-parkinsonism associated with a heterozygous PRKRA (DYT16) gene mutation

    J. Wu, M. Christie, M. Schiess (Houston, USA)

    Objective: We describe the clinical presentation, diagnosis, and treatment of a case of dystonia-parkinsonism associated with a heterozygous mutation in the initiator methionine of the…
  • « Previous Page
  • 1
  • …
  • 755
  • 756
  • 757
  • 758
  • 759
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley